ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.

Ingemar Lagerlöf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.